Endocrine Testing Market is Projected to Rise to US$12.8 bn by 2023, Says TMR

News provided by

19 Sep, 2018, 10:00 GMT

ALBANY, New York, September 19, 2018 /PRNewswire/ --

According to TMR, the global endocrine testing market will exhibit a CAGR of 8.5% between 2015 and 2023. At this pace, the market will reach US$12.8 bn by the end of 2023. Among end users, the market is likely to witness the highest demand from commercial laboratories segment. The rising trend of outsourcing various testing procedures will fuel the demand for endocrine testing from commercial laboratories. Regionally, North America is forecast to contribute the highest revenue towards the global endocrine testing market. However, in the coming years, the Asia Pacific market is expected to rise at a stellar CAGR and offer lucrative prospects for companies.

(Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg )

Rising Incidence of Chronic Diseases to Fuel Demand for Endocrine Testing

The demand for endocrine testing is expected to rise in response to the increasing incidence of diabetes and obesity around the world. A key point to note here is that monitoring the endocrine hormone is vital for the management of diabetes. This as per TMR is a crucial factor driving the market. Additionally, the rising incidence of cardiovascular diseases, cancer, and other ailments will fuel the demand for endocrine testing in the coming years.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1645

High Price of Endocrine Testing May Hinder Market's Trajectory

On the downside, the high price of advanced endocrine testing technologies has made them unaffordable across various developing and underdeveloped regions. This is a key factor hampering the market's growth rate. Besides this, limited awareness about healthcare facilities among people living in low-income region will hinder the market's trajectory to an extent.

Nonetheless, recent advancements in assays and various methods used for endocrine testing will enable growth in the market in the coming years. Furthermore, the market is likely to benefit from recent improvements in diagnostic technologies such as liquid chromatography-mass spectrometry (LC-MS). Spurred by these factors, the global endocrine testing market will exhibit steady growth over the course of the forecast period.

Request a Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645

The global endocrine testing market exhibits a fairly oligopolistic vendor landscape, with the top five companies occupying nearly 90% of the overall market in 2014, finds Transparency Market Research (TMR) in a new study. According to the report, DiaSorin, Abbott Laboratories, Siemens Healthineers, Agilent Technologies, and F. Hoffmann-La Roche AG emerged dominant in the global endocrine testing market in 2014. Among these companies, Roche led the overall market in the same year. In order to maintain a strong foothold in the global market, the leading companies are developing next-generation sequencing platforms, advanced lab automation systems, analyzers, and endocrine test kit.

Request a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1645

Currently, the market is witnessing intense competition among the leading companies and it is expected to get fiercer in the coming years. In order to steal a march against competition, the market players are likely to invest in expanding their product portfolio and developing innovative technologies. These strategies are likely to have positive influence on the overall market.

Browse Press Release: https://www.transparencymarketresearch.com/pressrelease/endocrine-testing-market.htm

This review is based on a TMR report, titled "Endocrine Testing Market (Test - Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Cortisol Test, Insulin Test Gastrin, Thymosin Secretin; Diagnostic Technology - Tandem Mass spectrometry, Immunoassay Technologies (Enzyme immunoassays and Radioimmunoassays (RIA)), Monoclonal and Polyclonal Antibody Technologies, Sensor Technologies (Electrochemical and Biosensors), Clinical Chemistry Technologies, and Liquid Chromatography-Mass Spectrometry (LC-MS); End User - Hospitals, Commercial Laboratories, Ambulatory Care Centers, Home Based Tests, and Physician Offices) - Global Industry Analysis, Size, Share, Growth Trends and Forecast, 2015 - 2023."

Popular Research Reports by TMR:

Chemiluminescence Immunoassay Analyzers Market:

https://www.transparencymarketresearch.com/chemiluminescence-immunoassay-analyzers-market.html

Fertility Testing Devices Market:

https://www.transparencymarketresearch.com/fertility-testing-devices-market.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com